CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.54
-0.23 (-2.35%)
Apr 16, 2025, 11:33 AM EDT - Market open

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
831943--
Market Cap Growth
-55.39%-55.39%---
Enterprise Value
46-2733--
Last Close Price
9.772.347.63--
PS Ratio
8.101.986.06--
PB Ratio
2.170.495.87--
P/TBV Ratio
2.170.495.87--
EV/Sales Ratio
4.73-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.370.371.01--
Quick Ratio
10.6110.613.360.311.48
Current Ratio
11.1111.113.840.321.50
Return on Equity (ROE)
-69.95%-69.95%---
Return on Assets (ROA)
-42.95%-42.95%-69.12%-39.59%-
Return on Capital (ROIC)
-48.91%-48.91%-90.49%-44.40%-
Earnings Yield
-1915.98%-84.35%-5.02%--
Buyback Yield / Dilution
-20334.10%-203.34%-413.65%88.49%-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q